Table 1 Clinicopathologic characteristics of 126 patients with bladder cancer
From: Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer
Clinical features | N (%) |
|---|---|
Mean age (minimum-maximum) | 66.8 (43–81) |
Sex | |
Male | 87 (69.0) |
Female | 39 (31.0) |
Stage | |
Ta | 48 (38.1) |
T1 | 46 (36.5) |
≥T2 | 32 (25.4) |
Grade | |
LMP | 32 (25.4) |
LG | 43 (34.1) |
HG | 51 (40.5) |
Carcinoma in situ | 26 (20.6) |
Surgical procedure | |
TUR | 90 (71.4) |
Cystectomy | 36 (28.6) |
Recurrence | 43 (34.1) |
pTa | 11 (25.6) |
pT1 | 23 (53.5) |
≥pT2 | 9 (20.9) |
Progression | 26 (18.8) |
pTa | 6 (23.1) |
pT1 | 11 (42.3) |
≥pT2 | 9 (34.6) |
Death | 65 (51.6) |
pTa | 12 (18.5) |
pT1 | 30 (46.2) |
≥pT2 | 23 (35.4) |